Novel coronavirus mitigation measures implemented by radiotherapy centres in low and middle-income countries: a systematic review
Abstract
Background: The aim of the study was to identify strategies adopted by radiotherapy centres in low- and middle-income countries (LMICs) to mitigate the effects of COVID-19.
Studies summarising COVID-19 mitigation strategies designed and implemented by radiotherapy centres in LMICs to avoid delays, deferrments and interruptions of radiotherapy services are lacking.
Materials and methods: A systematic review was conducted and reported in accordance with the preferred reporting items for systematic review and meta-analysis guideline. Ovid Embase, Ovid MEDLINE and CINAHL were searched for peer-reviewed articles that reported measures adopted by radiotherapy centres in LMICs to reduce the risk of COVID-19. Information on different strategies were extracted from the included studies and textual narrative synthesis was conducted.
Results: Of 60 articles retrieved, eleven were included. Majority of the studies were conducted in China. Ten of the included studies employed a qualitative design. Four themes were identified: preparing and equipping staff; reinforcing infection prevention and control policies; strengthening coordination and communication; and maintaining physical distancing. Studies reported that radiotherapy centres had: formed COVID-19 response multidisciplinary team; maximised the use of telehealth; adjusted the layout of waiting areas; divided staff into teams; dedicated a room for isolating suspected cases; and adopted triage systems.
Conclusions: Local adaptation of established global strategies coupled with timely development of guidelines, flexibility and innovation have allowed radiotherapy leaders to continue to deliver radiotherapy services to cancer patients in LMICs during the COVID-19 crisis. Robust data collection must be encouraged in LMICs to provide an evidence-based knowledge for use in the event of another pandemic.
Keywords: radiotherapycancerCOVID-19implementationlow and middle-income countries
References
- Chen TM, Rui J, Wang QP, et al. A mathematical model for simulating the phase-based transmissibility of a novel coronavirus. Infect Dis Poverty. 2020; 9(1): 24.
- Hopman J, Allegranzi B, Mehtar S. Managing COVID-19 in Low- and Middle-Income Countries. JAMA. 2020; 323(16): 1549–1550.
- Gostin, LO, Wiley LF. Governmental public health powers during the COVID-19 pandemic: stay-at-home orders, business closures, and travel restrictions. JAMA. 2020; 323(21): 2137–2138.
- Saini K, Heras Bd, Castro Jde, et al. Effect of the COVID-19 pandemic on cancer treatment and research. Lancet Haematol. 2020; 7(6): e432–e435.
- Wang H, Zhang Li. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020; 21(4): e181.
- Simcock R, Thomas TW, Mercy CE, et al. COVID-19: global radiation oncology’s targeted response for pandemic preparedness'. Clin Transl Radiat Oncol. 2020; 22: 55–68.
- Anderson N, Thompson K, Andrews J, et al. Planning for a pandemic: Mitigating risk to radiation therapy service delivery in the COVID-19 era. J Med Radiat Sci. 2020; 67(3): 1–6.
- Belkacemi Y, Grellier N, Ghith S, et al. A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low- and middle-income countries. Eur J Cancer. 2020; 135: 130–146.
- Vanderpuye V, Elhassan M, Simonds H. Preparedness for COVID-19 in the oncology community in Africa. Lancet Oncol. 2020; 21(5): 621–622.
- Moher D, Liberati A, Tetzlaff J, et al. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6(7): e1000097.
- Holmes J. Countertransference in qualitative research: a critical appraisal. Qualitative Res. 2013; 14(2): 166–183.
- Lucas PJ, Baird J, Arai L, et al. Worked examples of alternative methods for the synthesis of qualitative and quantitative research in systematic reviews. BMC Med Res Methodol. 2007; 7: 4.
- Wang W, Liu X, Zhang F, et al. Radiation Therapy During the COVID-19 Pandemic: Experience from Beijing, China. In Vivo. 2020; 34(3 Suppl): 1675–1680.
- Wei W, Zheng D, Lei Yu, et al. Radiotherapy workflow and protection procedures during the Coronavirus Disease 2019 (COVID-19) outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China. Radiother Oncol. 2020; 148: 203–210.
- Wu S, Zheng D, Liu Y, et al. Radiation therapy care during a major outbreak of COVID-19 in Wuhan. Adv Radiat Oncol. 2020; 5(4): 1–3.
- Xie C, Wang X, Liu H, et al. Infection control of 2019 novel corona virus disease (COVID-19) in cancer patients undergoing radiotherapy in Wuhan. medRxiv. 2020: 1–22.
- Aghili M, Jafari F, Vand Rajabpoor M. Brachytherapy during the coronavirus disease 2019 - Lessons from Iran. Brachytherapy. 2020; 19(4): 412–414.
- Motlagh A, Yamrali M, Azghandi S, et al. COVID19 Prevention & Care; A Cancer Specific Guideline. Arch Iran Med. 2020; 23(4): 255–264.
- Samiee S, Hadjilooei F, Alamolhoda M, et al. New Policy and Regulations for a Radiology-Oncology Center During the COVID-19 Outbreak in Tehran, Iran. Adv Radiat Oncol. 2020; 5(4): 550–557.
- Baldotto C, Gelatti A, Accioly A, et al. Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group. Clinics (Sao Paulo). 2020; 75: e2060.
- Lombe DC, Mwaba CK, Msadabwe SC, et al. Zambia's National Cancer Centre response to the COVID-19 pandemic-an opportunity for improved care. Ecancermedicalscience. 2020; 14: 1051.
- Gupta M, Ahuja R, Gupta S, et al. Running of high patient volume radiation oncology department during COVID-19 crisis in India: our institutional strategy. Radiat Oncol J. 2020; 38(2): 93–98.
- Saab R, Obeid A, Gachi F, et al. Impact of the coronavirus disease 2019 (COVID-19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia region: A report from the Pediatric Oncology East and Mediterranean (POEM) group. Cancer. 2020; 126(18): 4235–4245.
- Baldotto C, Gelatti A, Accioly A, et al. Lung Cancer and the COVID-19 pandemic: Recommendations from the Brazilian Thoracic Oncology Group. Clinics (Sao Paulo). 2020; 75: e2060.
- COVID-19: protecting health-care workers. Lancet. 2020; 395(10228): 922.
- UNICEF 2020, COVID-19 impact assessment and outlook on personal protective equipment. https://www.unicef.org/supply/stories/covid-19-impact-assessment-and-outlook-personal-protective-equipment (30/7/2020).
- Ranney ML, Griffeth V, Jha AK. Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic. N Engl J Med. 2020; 382(18): e41.
- Rowan NJ, Laffey JG. Challenges and solutions for addressing critical shortage of supply chain for personal and protective equipment (PPE) arising from Coronavirus disease (COVID19) pandemic - Case study from the Republic of Ireland. Sci Total Environ. 2020; 725: 138532.
- Fryer K, Delgado A, Foti T, et al. Implementation of obstetric telehealth during COVID-19 and beyond. Matern Child Health J. 2020; 24(9): 1104–1110.
- Monaghesh E, Hajizadeh A. The role of telehealth during COVID-19 outbreak:: a systematic review based on current evidence. BMC Public Health. 2020; 20(1): 1193.
- Nouri S, Khoong EC, Lyles CR, et al. Addressing equity in telemedicine for chronic disease management during the Covid-19 pandemic. NEJM Catalyst. 2020: 1–13.
- Aghili M, Ghalehtaki R, Mousavi Darzikolaee N, et al. Radiotherapy and COVID-19: Practical recommendations from iran. Radiother Oncol. 2020; 149: 70–71.
- Guckenberger M, Belka C, Bezjak A, et al. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol. 2020; 146: 223–229.
- Thomson DJ, Palma D, Guckenberger M, et al. Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement. Radiother Oncol. 2020; 151: 314–321.
- Portaluri M, Barba MC, Musio D, et al. Hypofractionation in COVID-19 radiotherapy: A mix of evidence based medicine and of opportunities. Radiother Oncol. 2020; 150: 191–194.